S&P 500   3,978.27 (+0.18%)
DOW   32,447.92 (+0.65%)
QQQ   308.37 (-0.81%)
AAPL   158.49 (-1.10%)
MSFT   276.30 (-1.52%)
META   202.32 (-1.79%)
GOOGL   102.69 (-2.61%)
AMZN   97.42 (-0.72%)
TSLA   191.56 (+0.60%)
NVDA   264.84 (-1.10%)
NIO   8.89 (-1.98%)
BABA   85.67 (-1.42%)
AMD   95.98 (-2.01%)
T   18.85 (+1.29%)
F   11.50 (-0.09%)
MU   59.69 (-2.40%)
CGC   1.88 (-1.05%)
GE   93.16 (+1.96%)
DIS   94.80 (+0.77%)
AMC   4.34 (-2.91%)
PYPL   73.39 (-0.66%)
PFE   40.32 (-0.17%)
NFLX   326.84 (-0.47%)
S&P 500   3,978.27 (+0.18%)
DOW   32,447.92 (+0.65%)
QQQ   308.37 (-0.81%)
AAPL   158.49 (-1.10%)
MSFT   276.30 (-1.52%)
META   202.32 (-1.79%)
GOOGL   102.69 (-2.61%)
AMZN   97.42 (-0.72%)
TSLA   191.56 (+0.60%)
NVDA   264.84 (-1.10%)
NIO   8.89 (-1.98%)
BABA   85.67 (-1.42%)
AMD   95.98 (-2.01%)
T   18.85 (+1.29%)
F   11.50 (-0.09%)
MU   59.69 (-2.40%)
CGC   1.88 (-1.05%)
GE   93.16 (+1.96%)
DIS   94.80 (+0.77%)
AMC   4.34 (-2.91%)
PYPL   73.39 (-0.66%)
PFE   40.32 (-0.17%)
NFLX   326.84 (-0.47%)
S&P 500   3,978.27 (+0.18%)
DOW   32,447.92 (+0.65%)
QQQ   308.37 (-0.81%)
AAPL   158.49 (-1.10%)
MSFT   276.30 (-1.52%)
META   202.32 (-1.79%)
GOOGL   102.69 (-2.61%)
AMZN   97.42 (-0.72%)
TSLA   191.56 (+0.60%)
NVDA   264.84 (-1.10%)
NIO   8.89 (-1.98%)
BABA   85.67 (-1.42%)
AMD   95.98 (-2.01%)
T   18.85 (+1.29%)
F   11.50 (-0.09%)
MU   59.69 (-2.40%)
CGC   1.88 (-1.05%)
GE   93.16 (+1.96%)
DIS   94.80 (+0.77%)
AMC   4.34 (-2.91%)
PYPL   73.39 (-0.66%)
PFE   40.32 (-0.17%)
NFLX   326.84 (-0.47%)
S&P 500   3,978.27 (+0.18%)
DOW   32,447.92 (+0.65%)
QQQ   308.37 (-0.81%)
AAPL   158.49 (-1.10%)
MSFT   276.30 (-1.52%)
META   202.32 (-1.79%)
GOOGL   102.69 (-2.61%)
AMZN   97.42 (-0.72%)
TSLA   191.56 (+0.60%)
NVDA   264.84 (-1.10%)
NIO   8.89 (-1.98%)
BABA   85.67 (-1.42%)
AMD   95.98 (-2.01%)
T   18.85 (+1.29%)
F   11.50 (-0.09%)
MU   59.69 (-2.40%)
CGC   1.88 (-1.05%)
GE   93.16 (+1.96%)
DIS   94.80 (+0.77%)
AMC   4.34 (-2.91%)
PYPL   73.39 (-0.66%)
PFE   40.32 (-0.17%)
NFLX   326.84 (-0.47%)
NYSE:NHI

National Health Investors - NHI Stock Forecast, Price & News

$50.23
+0.87 (+1.76%)
(As of 03/27/2023 12:45 PM ET)
Add
Compare
Today's Range
$49.60
$50.31
50-Day Range
$48.25
$59.60
52-Week Range
$48.04
$67.16
Volume
48,758 shs
Average Volume
275,671 shs
Market Capitalization
$2.18 billion
P/E Ratio
34.17
Dividend Yield
7.17%
Price Target
$61.25

National Health Investors MarketRank™ Forecast

Analyst Rating
Hold
2.25 Rating Score
Upside/​Downside
23.1% Upside
$61.25 Price Target
Short Interest
Healthy
2.32% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-2.59
Upright™ Environmental Score
News Sentiment
0.00mentions of National Health Investors in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
8.49%
From $4.24 to $4.60 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.38 out of 5 stars

Finance Sector

677th out of 884 stocks

Real Estate Investment Trusts Industry

146th out of 189 stocks


NHI stock logo

About National Health Investors (NYSE:NHI) Stock

National Health Investors, Inc. engages in the sale-leaseback, joint-venture, mortgage, and mezzanine financing of senior housing and medical investments. It operates through the Real Estate Investments and Senior Housing Operating Portfolio (SHOP) segments. The Real Estate Investments segment includes real estate investments and lease, mortgage, and other notes receivables in independent living facilities. The SHOP segment is involved in two ventures that own the operations of independent living facilities. The company was founded by W. Andrew Adams in 1991 and is headquartered in Murfreesboro, TN.

Receive NHI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for National Health Investors and its competitors with MarketBeat's FREE daily newsletter.

NHI Stock News Headlines

This Critical Metal May Soon Power Our Future!
The World Is Racing Towards Renewable Energy! And These Metal May Be The Key Element.pixel
National Health Investors: NHI Issues Investor Update
NHI Announces Fourth Quarter 2022 Results
NHI Announces First Quarter 2023 Dividend
NHI Issues Investor Update
This Critical Metal May Soon Power Our Future!
The World Is Racing Towards Renewable Energy! And These Metal May Be The Key Element.pixel
6%-Yielding National Health Investors: No Pain, No Gain
NHI Announces Third Quarter 2022 Results
Douglas Emmett (DEI) Matches Q3 FFO Estimates
See More Headlines
Receive NHI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for National Health Investors and its competitors with MarketBeat's FREE daily newsletter.

NHI Company Calendar

Last Earnings
5/09/2022
Ex-Dividend for 1/27 Dividend
12/29/2022
Dividend Payable
1/27/2023
Today
3/27/2023
Ex-Dividend for 5/5 Dividend
3/30/2023
Dividend Payable
5/05/2023
Next Earnings (Estimated)
5/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Real estate investment trusts
Sub-Industry
Specialized REITs
Sector
Finance
CUSIP
63633D10
Employees
19
Year Founded
1991

Price Target and Rating

Average Stock Price Forecast
$61.25
High Stock Price Forecast
$64.00
Low Stock Price Forecast
$58.00
Forecasted Upside/Downside
+24.1%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

Net Income
$66.40 million
Pretax Margin
23.55%

Debt

Sales & Book Value

Annual Sales
$278.19 million
Cash Flow
$3.50 per share
Book Value
$29.50 per share

Miscellaneous

Free Float
40,239,000
Market Cap
$2.14 billion
Optionable
Optionable
Beta
0.90

Social Links


Key Executives

  • D. Eric Mendelsohn
    President, Chief Executive Officer & Director
  • John L. Spaid
    Chief Financial Officer & Executive VP-Finance
  • Kevin C. Pascoe
    Chief Investment Officer
  • Kristin Sallee Gaines
    Chief Transaction Officer
  • Michelle Kelly
    Senior Vice President-Investments













NHI Stock - Frequently Asked Questions

Should I buy or sell National Health Investors stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for National Health Investors in the last twelve months. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" NHI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NHI, but not buy additional shares or sell existing shares.
View NHI analyst ratings
or view top-rated stocks.

What is National Health Investors' stock price forecast for 2023?

4 brokers have issued 1-year target prices for National Health Investors' stock. Their NHI share price forecasts range from $58.00 to $64.00. On average, they predict the company's stock price to reach $61.25 in the next year. This suggests a possible upside of 24.1% from the stock's current price.
View analysts price targets for NHI
or view top-rated stocks among Wall Street analysts.

How have NHI shares performed in 2023?

National Health Investors' stock was trading at $52.22 at the beginning of 2023. Since then, NHI shares have decreased by 5.5% and is now trading at $49.36.
View the best growth stocks for 2023 here
.

When is National Health Investors' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 8th 2023.
View our NHI earnings forecast
.

How were National Health Investors' earnings last quarter?

National Health Investors, Inc. (NYSE:NHI) issued its quarterly earnings data on Monday, May, 9th. The real estate investment trust reported $0.18 earnings per share for the quarter, missing the consensus estimate of $0.63 by $0.45. The real estate investment trust earned $71.33 million during the quarter, compared to the consensus estimate of $73.06 million. National Health Investors had a trailing twelve-month return on equity of 4.84% and a net margin of 23.87%. The business's quarterly revenue was down 11.8% compared to the same quarter last year. During the same period last year, the firm earned $1.24 earnings per share.

How often does National Health Investors pay dividends? What is the dividend yield for National Health Investors?

National Health Investors announced a quarterly dividend on Tuesday, February 21st. Investors of record on Friday, March 31st will be given a dividend of $0.90 per share on Friday, May 5th. This represents a $3.60 dividend on an annualized basis and a dividend yield of 7.29%. The ex-dividend date of this dividend is Thursday, March 30th.
Read our dividend analysis for NHI
.

Is National Health Investors a good dividend stock?

National Health Investors (NYSE:NHI) pays an annual dividend of $3.60 per share and currently has a dividend yield of 7.46%. NHI has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 244.90%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, NHI will have a dividend payout ratio of 78.26% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for NHI.

What guidance has National Health Investors issued on next quarter's earnings?

National Health Investors issued an update on its FY 2023 earnings guidance on Tuesday, February, 21st. The company provided EPS guidance of $4.24-$4.30 for the period. The company issued revenue guidance of -.

What other stocks do shareholders of National Health Investors own?

Based on aggregate information from My MarketBeat watchlists, some companies that other National Health Investors investors own include AT&T (T), AbbVie (ABBV), Verizon Communications (VZ), Cisco Systems (CSCO), Annaly Capital Management (NLY), JPMorgan Chase & Co. (JPM), Simon Property Group (SPG), Energy Transfer (ET), QUALCOMM (QCOM) and Broadcom (AVGO).

What is National Health Investors' stock symbol?

National Health Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "NHI."

Who are National Health Investors' major shareholders?

National Health Investors' stock is owned by many different institutional and retail investors. Top institutional shareholders include Macquarie Group Ltd. (2.58%), Geode Capital Management LLC (2.05%), Bank of America Corp DE (1.78%), American Century Companies Inc. (1.64%), Charles Schwab Investment Management Inc. (1.47%) and Dimensional Fund Advisors LP (1.40%). Insiders that own company stock include Robert G Adams and Robert T Webb.
View institutional ownership trends
.

How do I buy shares of National Health Investors?

Shares of NHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is National Health Investors' stock price today?

One share of NHI stock can currently be purchased for approximately $49.36.

How much money does National Health Investors make?

National Health Investors (NYSE:NHI) has a market capitalization of $2.14 billion and generates $278.19 million in revenue each year. The real estate investment trust earns $66.40 million in net income (profit) each year or $1.47 on an earnings per share basis.

How can I contact National Health Investors?

National Health Investors' mailing address is 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129. The official website for the company is www.nhireit.com. The real estate investment trust can be reached via phone at (615) 890-9100, via email at investorrelations@nhireit.com, or via fax at 615-225-3030.

This page (NYSE:NHI) was last updated on 3/27/2023 by MarketBeat.com Staff